​Why isn't heparin effective in severe COVID-19 thrombosis?

Written By Sofia Villar

Stay tuned for an exciting Covid-19 study ​and a newly identified thrombosis biomarker to be presented at the American Heart Association meeting on Nov 13th by our founder, Dr. David Farrell, Professor at OHSU Medical School, Founder and Chief Scientific Officer at Gamma Diagnostics, Inc.

Sofia Villar
Previous

What is Gamma Prime Fibrinogen?
Next

Gamma Diagnostics Joins Expert Dojo's Healthcare Cohort